Perspective: Cell differentiation theory may advance early detection of and therapy for lung cancer

Radiation Research

Volumn 155, Issue 1, 2001, Pages 235-238

  Lechner, John F ^a,d   Fugaro, Joseph M ^a   Wong, Yongxin ^a   Pass, Harvey I ^a   Harris, Curtis C ^b   Belinsky, Steven A ^c  

^a KARMANOS CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^d HWCRC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; GENETICS; HOMEOBOX; HUMAN; LUNG TUMOR; PATHOLOGY;

CELL DIFFERENTIATION; GENES, HOMEOBOX; HUMANS; LUNG NEOPLASMS;

EID: 0035218601     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2001)155[0235:PCDTMA]2.0.CO;2     Document Type: Review

References (44)

1. R. Ruddon, Cancer: A disease of abnormal differentiation. In Cancer Biology, 2nd ed., pp. 164-189. Oxford University Press, New York, 1987.
2. V. R. Potter, Recent trends in cancer biochemistry: The importance of studies on fetal tissue. Can. Cancer Conf. 8, 9-30 (1969).
3. S. Sell and G. B. Pierce, Maturation arrest of stem cells differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab. Invest. 70, 6-22 (1994).
4. W. R. Otto, Lung stem cells. Int. J. Exp. Pathol. 78, 291-310 (1997).
5. S. M. Magdoleno, J. Barrish, M. J. Finegold and F. J. DeMayo, Investigating stem cells in the lung. Adv. Pediatr. 44, 383-396 (1998).
6. M. D. Mason, Differentiation and cancer. Br. J. Cancer 28, 255-258 (1992).
7. A. A. W. Ten Have-Opbrek, J. R. Benfield, W. G. Hammond, R. L. Teplitz and J. H. Dijkman, In favour of an oncofoetal concept of bronchogenic carcinoma development. Histol. Histopathol. 9, 375-384 (1994).
8. W. J. Gehring, M. Affolter and T. Bükglin, Homeodomain proteins. Annu. Rev. Biochem. 63, 487-526 (1994).
9. F. Apiou, D. Flagiello, C. Cillo, B. Malfoy, M. F. Poupon and B. Dutrillaux, Fine mapping of human HOX gene clusters. Cytogenet. Cell Genet. 73, 114-115 (1996).
10. C. C. Maulbecker and P. Gruss, The oncogenic potential of deregulated homeobox genes. Cell Growth Differ. 4, 431-441 (1993).
11. H. L. Ford, Homeobox genes: A link between development, cell cycle, and cancer? Cell Biol. Int. 22, 397-400 (1998).
12. C. Cillo, A. Faiella, M. Cantile and E. Boncinelli, Homeobox genes and cancer. Exp. Cell Res. 248, 109 (1999).
13. U. M. Wewer, A. M. Mercurio, S. Y. Chung and R. Albrechtsen, Deoxyribonucleic-binding homeobox proteins are augmented in human cancer. Lab. Invest. 63, 447-454 (1990).
14. C. Tiberio, P. Barba, M. C. Magli, F. Arvelo, T. Le Chevalier, M. F. Poupon and C. Cillo, HOX gene expression in human small-cell lung cancers xenografted into nude mice. Int. J. Cancer 58, 608-615 (1994).
15. D. Flagiello, A. Gibaud, B. Dutrillaux, M. F. Poupon and B. Malfoy, Distinct patterns of all-trans retinoic acid dependent expression of HOXB and HOXC homeogenes in human embryonal and small-cell lung carcinoma cell lines. FEBS Lett. 415, 263-267 (1997).
16. W. V. Cardoso, Transcription factors and pattern formation in the developing lung. Am. J. Physiol. 269, L429-L442 (1995).
17. C. Kappen, Hox genes in the lung. Am. J. Respir. Cell Mol. Biol. 15, 156-162 (1996).
18. C. W. Bogue, I. Gross, H. Vasavada, D. W. Dynia, C. M. Wilson and H. C. Jacobs, Identification of Hox genes in newborn lung and effects of gestational age and retinoic acid on their expression. Am. J. Physiol. 266, L448-L454 (1994).
19. F. R. Goodman, S. Mundlos, Y. Muragaki, D. Donnai, M. L. Giovannucci-Uzielli, E. Lapi, F. Majewski, J. McGaughran, C. McKeown and P. J. Scambler, Synpolydactyly phenotypes correlate with size of expansions in HOXD1 3 polyalanine tract. Proc. Natl. Acad. Sci. USA 94, 7458-7463 (1997).
20. 2BP, a specific inhibitor of pADPRT. Int. J. Mol. Med. 4, S1-S7 (1999). [Abstract]
21. Cancer Facts and Figures. American Cancer Society, 1999.
22. G. Saccomanno, R. P. Saunders, V. E. Archer, O. Auerbach, M. Kuschner and P. A. Beckler, Cancer of the lung: The cytology of sputum prior to the development of carcinoma. Acta Cytol. 9, 413-423 (1965).
23. J. J. Bechtel, W. R. Kelley, T. L. Petty, D. S. Patz and G. Saccomanno, Outcome of 51 patients with roentgenographically occult lung cancer detected by sputum cytologic testing: A community hospital program. Arch. Intern. Med. 154, 975-980 (1994).
24. D. M. Eddy, Screening for lung cancer. Ann. Intern. Med. 111, 232-237 (1989).
25. D. Sidransky, Molecular markers in cancer diagnosis. J. Natl. Cancer Inst. Monogr. 27-29 (1995).
26. P. J. Villeneuve and Y. Mao, Lifetime probability of developing lung cancer, by smoking status, Canada. Can. J. Public Health 85, 385-388 (1994).
27. M. T. Halpern, B. W. Gillespie and K. E. Warner, Patterns of absolute risk of lung cancer mortality in former smokers. J.Natl. Cancer Inst. 85, 457-464 (1993).
28. N. C. J. Clements, M. A. Nelson, J. A. Wymer, C. Savage, M. Aguirre and H. Garewal, Analysis of K-ras gene mutations in malignant and nonmalignant endobronchial tissue obtained by fiberoptic bronchoscopy. Am. J. Respir. Crit. Care Med. 152, 1374-1378 (1995).
29. W. A. Franklin, A. F. Gazdar, J. Haney, I. I. Wistuba, F. G. La Rosa, T. Kennedy, D. M. Ritchie and Y. E. Miller, Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J. Clin. Invest. 100, 2133-2137 (1997).
30. L. Mao, J. S. Lee, J. M. Kurie, Y. H. Fan, S. M. Lippman, J. J. Lee, J. Y. Ro, A. Broxson, R. Yu and W. K. Hong, Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst. 89, 857-862 (1997).
31. E. R. Fearon, The smoking gun and the damage done: Genetic alterations in the lungs of smokers. J. Natl. Cancer Inst. 89, 834-836 (1997).
32. I. I. Wistuba, S. Lam, C. Behrens, A. K. Virmani, K. M. Fong, J. LeRiche, J. M. Samet, S. Srivastava, J. D. Minna and A. F. Gazdar, Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst. 89, 1366-1373 (1997).
33. G. Sozzi, M. Miozzo, E. Tagliabue, C. Calderone, L. Lombardi, S. Pilotti, U. Pastorini, M. A. Pierotti and G: Della Portia, Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res. 51, 400-404 (1991).
34. J. K. Field, T. Liloglou, G. Xinarianos, W. Prime, P. Fielding, M. J. Walshwa and L. Turnbull, Genetic alterations in bronchial lavage as a potential marker for individuals with a high risk of developing lung cancer. Cancer Res. 59, 2690-2695 (1999).
35. R. E. Neft, R. E. Crowell, F. D. Gilliland, M. M. Murphy, J. L. Lane, H. Harms, T. Coons, E. Heaphy, S. A. Belinsky and J. F. Lechner, Frequency of trisomy 20 in nonmalignant bronchial epithelium from lung cancer patients and cancer-free former uranium miners and smokers. Cancer Epidemiol. Biomarkers. Prev. 7, 1051-1054 (1989).
36. J. F. Lechner, R. E. Neft, F. D. Gilliland, R. E. Crowell, D. H. Auckley, R. T. Temes and S. A. Belinsky, Individuals at high risk for lung cancer have airway epithelial cells with chromosome aberrations frequently found in lung tumor cells. In Vivo 12, 23-26 (1998).
37. J. F. Lechner, R. E. Neft, F. D. Gilliland and S. A. Belinsky, Molecular identification of individuals at high risk for lung cancer. Radiat. Oncol. Invest. 5, 103-105 (1997).
38. R. E. Crowell, F. D. Gilliland, R. T. Temes, H. J. Harms, R. E. Neft, E. Heaphy, D. H. Auckley, L. A. Crooks, S. W. Jordan and S. A. Belinsky, Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer. Cancer Epidemiol. Biomarkers Prev. 5, 631-637 (1996).
39. P. Economou, J. F. Lechner and J. M. Samet, Familial and genetic factors in the pathogenesis of lung cancer. In Epidemiology of Lung Cancer (J. M. Samet, Ed.), pp. 353-396. Marcel Dekker, New York, 1994.
40. E. R. Fearon and B. Vogelstein, A genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990).
41. R. L. De Silva, R. L. Moy, J. F. Lechner and R. R. Reddel, Immortalization of human bronchial epithelial cells. In Culture of Immortalized Cells (R. I. Freshney, Ed.), pp. 239-257. Wiley-Liss, New York, 1996.
42. R. P. Warrell, Jr., L Z. He, V. Richon, E. Calleja and P. P. Pandolfi, Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J. Natl. Cancer Inst. 90, 1621-1625 (1998).
43. H. C. Jacobs, C. W. Bogue, E. Pinter, C. M. Wilson, J. B. Warshaw and I. Gross, Fetal lung mRNA levels of Hox genes are differentially altered by maternal diabetes and butyrate in rats. Pediatr. Res. 44, 99-104 (1998).
44. M. R. Chinoy, M. V. Volpe, R. E. Cilley, S. E. Zleszewski, R. J. Vosatka, A. Martin, H. C. Nielsen and T. M. Krummel, Growth factors and dexamethasone regulate Hoxb5 protein in cultured murine fetal lungs. Am. J. Physiol. 274, L610-L620 (1998).